Carvajal Cristina, Dumont Yvan, Herzog Herbert, Quirion Rémi
Douglas Hospital Research Centre, Department of Neurology and Neurosurgery, Department of Psychiatry, McGill University, Montréal QC, Canada H4H 1R3.
J Mol Neurosci. 2006;28(3):239-45. doi: 10.1385/JMN:28:3:239.
Neuropeptide Y (NPY) was shown to modulate anxiety- and depression-related behaviors in various animal models. Previous studies demonstrated that NPY Y2 receptor knockout (KO) mice display an anxiolytic- and antidepressant-like phenotype compared with control animals. However, the long-term effect of the deletion of this receptor in aged animals is unknown. Thus, anxiety- and depression-related behaviors were investigated in 2-yr-old NPY Y2 KO mice. Aged NPY Y2 KO mice display an anxiolytic-like profile as assessed in the elevated plus-maze and open field, providing further support for a role for Y2 receptors in anxiety-related behaviors. Furthermore, aged NPY Y2 KO mice have significantly lower immobility scores in the forced swim test; supporting the role for this receptor in antidepressant-like behaviors. These data provide further evidence that modulators of the NPY Y2 receptor subtype are drug targets for the treatment of anxiety and mood disorders in human subjects.
神经肽Y(NPY)已被证明可在多种动物模型中调节与焦虑和抑郁相关的行为。先前的研究表明,与对照动物相比,NPY Y2受体敲除(KO)小鼠表现出抗焦虑和抗抑郁样表型。然而,在老年动物中缺失该受体的长期影响尚不清楚。因此,对2岁的NPY Y2 KO小鼠的焦虑和抑郁相关行为进行了研究。在高架十字迷宫和旷场试验中评估,老年NPY Y2 KO小鼠表现出抗焦虑样特征,为Y2受体在焦虑相关行为中的作用提供了进一步支持。此外,老年NPY Y2 KO小鼠在强迫游泳试验中的不动时间显著降低;支持该受体在抗抑郁样行为中的作用。这些数据进一步证明,NPY Y2受体亚型的调节剂是治疗人类焦虑和情绪障碍的药物靶点。